Bio-Convert ApS, a Denmark-based clinical-stage biopharmaceutical company, is aiming to revolutionize the treatment of oral leukoplakia, by minimizing or removing oral leukoplakia lesions, that ...
The biomarker assay can be used potentially to enrich clinical trials and monitor patients' disease activity and treatment response.
Highlights: Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis Orphan Designation offers 10 ...
Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS ...
Nordic Semiconductor ASA (GB:0FF9) has released an update. Nordic Semiconductor has announced a strategic realignment that includes an 8% global workforce reduction to enhance efficiency and focus ...
--(BUSINESS WIRE)--ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive ...
Please use one of the following formats to cite this article in your essay, paper or report: APA Axol Bioscience Ltd. (2024, October 22). Axol Bioscience acquires Phenocell to advance human ...
In 2022, American bioscience company Colossal Biosciences announced it had formed a partnership with a research lab at the University of Melbourne to bring the marsupial back, a plan that has ...
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug ...
Shift Bioscience is building a cell simulation platform that combines generative AI with its highly accurate, high-throughput biological aging clock, to predict which sets of genes are most likely ...
The Nordic diet, often called the Scandinavian diet, is based on the traditional eating patterns in the Nordic countries (Denmark, Sweden, Finland, Norway, and Iceland). It prioritizes locally and ...
Shift Bioscience, a Cambridge biotech using generative AI models to understand how activation of different genes can reverse the ageing process, has raised $16 million seed cash. BGF lead the round, ...